Sectors
HOWL
Werewolf Therapeutics, Inc.
0.40
5 x 0.37
5 x 0.43
bid
ask
+
0.02
4.08%
09:40 AM
timesize
| Ytd | -37.29% | |
| 1y | -66.02% |
0.39
day range
0.40
0.27
52 week range
2.38
| Open | 0.40 | Prev Close | 0.38 | Low | 0.39 | High | 0.40 | Mkt Cap | 19.32M |
| Vol | 6.24K | Avg Vol | 756.20K | EPS | -1.24 | P/E | -0.32 | Forward P/E | -0.86 |
| Beta | 0.29 | Short Ratio | 2.09 | Inst. Own | 72.62% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 0.38 | 200-d Avg | 0.71 | 1yr Est | 12.00 |
| Income Statement | |||
| Total Revenue | 21.00M | ||
| Revenues (USD) | 21.00M | ||
| Gross Profit | 21.00M | ||
| Operating Expenses | 13.84M | ||
| Research and Development Expense | 6.16M | ||
| Selling, General and Administrative Expense | 7.68M | ||
| Operating Income | 7.16M | ||
| Interest Expense | 475.00K | ||
| Net Income | 3.67M | ||
| Net Income Common Stock | 3.67M | ||
| Net Income Common Stock (USD) | 3.67M | ||
| Consolidated Income | 3.67M | ||
| Earnings per Basic Share | 0.08 | ||
| Earnings per Basic Share (USD) | 0.08 | ||
| Earnings per Diluted Share | 0.08 | ||
| Earning Before Interest & Taxes (EBIT) | 4.14M | ||
| Earning Before Interest & Taxes (USD) | 4.14M | ||
| Weighted Average Shares | 48.60M | ||
| Weighted Average Shares Diluted | 48.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 21.99M | ||
| Cash and Equivalents (USD) | 21.99M | ||
| Current Assets | 22.89M | ||
| Property, Plant & Equipment Net | 1.26M | ||
| Total Assets | 24.16M | ||
| Current Liabilities | 7.86M | ||
| Total Liabilities | 7.86M | ||
| Accumulated Retained Earnings (Deficit) | -485.27M | ||
| Shareholders Equity | 16.29M | ||
| Shareholders Equity (USD) | 16.29M | ||
| Assets Non-Current | 1.26M | ||
| Trade and Non-Trade Payables | 1.94M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.54M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -25.37M | ||
| Net Cash Flow from Operations | 6.63M | ||
| Share Based Compensation | 419.00K | ||